US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 BuyWrite ETF

21.56

-0.2400-1.10%

Post-market: 21.560.00000.00%17:15 EDT

Volume:72.31K

Turnover:1.56M

Market Cap:311.54M

PE:- -

High:21.78

Open:21.78

Low:21.52

Close:21.80

52wk High:23.10

52wk Low:19.41

Shares:14.45M

Float Shares:14.45M

Volume Ratio:1.89

T/O Rate:0.50%

Dividend:2.56

Dividend Rate:11.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026

Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PBP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBP\",,,,,undefined,":{"symbol":"PBP","market":"US","secType":"STK","nameCN":"Invesco S&P 500 BuyWrite ETF","latestPrice":21.56,"timestamp":1774641600000,"preClose":21.8,"halted":0,"volume":72309,"hourTrading":{"tag":"盘后","latestPrice":21.56,"preClose":21.56,"latestTime":"17:15 EDT","volume":43,"amount":927.61,"timestamp":1774646100349,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011009174311926696,"floatShares":14450000,"shares":14450000,"eps":0,"marketStatus":"Market Closed","change":-0.24,"latestTime":"03-27 16:00:00 EDT","open":21.78,"high":21.78,"low":21.52,"amount":1564937.987712,"amplitude":0.011927,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":21.8,"sharesOutstanding":14400000,"nav":21.76053,"aum":311203403.39,"dividendRate":0.118627,"bidAskSpread":0.00169,"postHourTrading":{"tag":"盘后","latestPrice":21.56,"preClose":21.56,"latestTime":"17:15 EDT","volume":43,"amount":927.61,"timestamp":1774646100349,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8895784758056007,"impliedVol":0.0027,"impliedVolPercentile":0.1793},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBP\",,,,,undefined,":{"symbol":"PBP","floatShares":14450000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.8895784758056007,"shares":14450000,"dividePrice":2.5576,"high":21.78,"amplitude":0.011927,"preClose":21.8,"low":21.52,"week52Low":19.4101,"pbRate":"--","week52High":23.1,"institutionHeld":0,"latestPrice":21.56,"eps":0,"divideRate":0.118627,"volume":72309,"delay":0,"ttmEps":0,"open":21.78,"prevYearClose":22.8297,"prevWeekClose":21.91,"prevMonthClose":22.7835,"prevQuarterClose":22.8297,"fiveDayClose":21.91,"twentyDayClose":22.7835,"sixtyDayClose":22.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBP\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"PBP","amount":0.19305,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 BuyWrite ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2026-02-23","symbol":"PBP","amount":0.20355,"announcedDate":"2026-02-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-23","defaultRemindTime":1771857000000,"name":"Invesco S&P 500 BuyWrite ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-23","currency":"USD","dateTimestamp":1771822800000,"payDate":"2026-02-27"},{"date":"2026-01-20","symbol":"PBP","amount":0.21266,"announcedDate":"2026-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-20","defaultRemindTime":1768919400000,"name":"Invesco S&P 500 BuyWrite ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-23","payableDate":"2026-01-20","currency":"USD","dateTimestamp":1768885200000,"payDate":"2026-01-23"},{"date":"2025-12-22","symbol":"PBP","amount":0.39405,"announcedDate":"2025-11-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 BuyWrite ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-11-24","symbol":"PBP","amount":0.22219,"announcedDate":"2025-11-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-24","defaultRemindTime":1763994600000,"name":"Invesco S&P 500 BuyWrite ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-24","currency":"USD","dateTimestamp":1763960400000,"payDate":"2025-11-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBP\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-30","value":0.10251,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.07876,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.14385,"currency":"USD"},{"executeDate":"2016-12-27","recordDate":"2016-12-29","paymentDate":"2016-12-30","value":0.17597,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.47258,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612460914","title":"Press Release: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460914?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 17, 2026  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2025 and introduced its annual guidance for the year ending December 31, 2026.Fourth Quarter 2025 Financial Highlights & Key Metrics. -- Net sales of $32.1 million, up 57% compared to $20.4 million in the. -- Durable Medical Equipment  channel net sales of $22.3 million,up 24% compared to $18.0 million in the fourth quarter of 2024.-- Pharmacy Benefit Plan  channel net sales of $9.8 million, up. 295% compared to $2.5 million in the fourth quarter of 2024.-- Gross margin of 59.0%, up 179 basis points compared to 57.2% in the. -- Installed customer base (calculated as all new patient starts over a. rolling four-year period) of 35,011 users, up 129% compared to 15,298 in. -- 5,592 new patient starts, up 37% compared to 4,084 new patient starts in. -- 69% of new patient start","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBP","BK4082","BBNX"],"gpt_icon":0},{"id":"2602313994","title":"Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313994","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313994?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:04","pubTimestamp":1767906240,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan.  08, 2026  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215777/0/en/Beta-Bionics-Announces-Preliminary-Unaudited-Fourth-Quarter-2025-Topline-Financial-Results-and-Key-Metrics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","PBP","BK4082"],"gpt_icon":0},{"id":"2589358724","title":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358724","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358724?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:45","pubTimestamp":1765197900,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  08, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201441/0/en/Beta-Bionics-to-Pre-Announce-Topline-Fourth-Quarter-2025-Financial-Results-the-Week-of-January-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBP","BK4082","BBNX"],"gpt_icon":0},{"id":"2579997983","title":"Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579997983","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579997983?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:02","pubTimestamp":1761681720,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175926/0/en/Beta-Bionics-Reports-Third-Quarter-2025-Financial-Results-and-Raises-Full-Year-2025-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4082","LU1169589451.USD","BBNX","PBP","BK4181","PD","LU1169590202.USD","PK","BK4023"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBP\",params:#limit:6,delay:false,,,undefined,":[]}}